Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Small molecule natural compound agonist of SIRT3 as a therapeutic target for the treatment of intervertebral disc degeneration
oleh: Jianle Wang, Majid Nisar, Chongan Huang, Xiangxiang Pan, Dongdong Lin, Gang Zheng, Haiming Jin, Deheng Chen, Naifeng Tian, Qianyu Huang, Yue Duan, Yingzhao Yan, Ke Wang, Congcong Wu, Jianing Hu, Xiaolei Zhang, Xiangyang Wang
Format: | Article |
---|---|
Diterbitkan: | Nature Publishing Group 2018-11-01 |
Deskripsi
Disc degeneration: a potential defense against damaged discs Molecules that counteract metabolic abnormalities in spinal tissue could help treat lower back pain associated with disc degeneration. In this condition, the cells that form the discs experience heightened oxidative stress, wherein mitochondria produce high levels of toxic compounds. Researchers in China led by Xiangyang Wang of the Second Affiliated Hospital of Wenzhou Medical University and Xiaolei Zhang of the Zhejiang Provincial Key Laboratory of Orthopedics have identified a molecular target that may enable doctors to prevent this damage. They determined that a protein called SIRT3 plays a critical role in mitigating oxidative stress, and that its loss renders stressed disc tissue especially vulnerable. The researchers also found that honokiol—a SIRT3-activating compound derived from magnolia tree bark—effectively prevents disc degeneration in rats. A similar treatment strategy could potentially prove beneficial in human patients.